loading page

Demographic and travel characteristics and self-reported pre-departure SARS-CoV-2 testing behavior in air passengers entering the United States from foreign destinations from July to September 2021
  • +7
  • Anthony Panasci,
  • Shannon Gearhart,
  • Anna Shaum,
  • Arthur Simental,
  • Colby Mitchell,
  • Dionne Mitcham,
  • Gilandria Williams,
  • Nadim Shake,
  • Clive Brown,
  • Alida Gertz
Anthony Panasci
Centers for Disease Control and Prevention

Corresponding Author:[email protected]

Author Profile
Shannon Gearhart
Centers for Disease Control and Prevention
Author Profile
Anna Shaum
Centers for Disease Control and Prevention
Author Profile
Arthur Simental
Centers for Disease Control and Prevention
Author Profile
Colby Mitchell
Centers for Disease Control and Prevention
Author Profile
Dionne Mitcham
Centers for Disease Control and Prevention
Author Profile
Gilandria Williams
Centers for Disease Control and Prevention
Author Profile
Nadim Shake
Centers for Disease Control and Prevention
Author Profile
Clive Brown
Centers for Disease Control and Prevention
Author Profile
Alida Gertz
Centers for Disease Control and Prevention
Author Profile

Abstract

From January 2021 to June 2022, CDC required pre-departure SARS-CoV-2 testing for all air passengers arriving into the United States. Using data collected during a pilot surveillance program, this manuscript describes pre-departure testing behavior among a convenience sample of international air passengers entering the United States from July to September 2021 at six US ports of entry. We analyzed pairwise relationships between self-reported test type, test timing, demographic and travel characteristics, and COVID-19 vaccination status. We found that test type was significantly associated with departure region, likely reflecting the regional disparities in the availability of tests at the time of the activity.
06 Jan 2023Submitted to Immunity, Inflammation and Disease
10 Jan 2023Submission Checks Completed
10 Jan 2023Assigned to Editor
10 Jan 2023Review(s) Completed, Editorial Evaluation Pending
13 Jan 2023Reviewer(s) Assigned
17 Apr 2023Editorial Decision: Revise Major
29 Jun 20231st Revision Received
02 Jul 2023Submission Checks Completed
02 Jul 2023Assigned to Editor
02 Jul 2023Review(s) Completed, Editorial Evaluation Pending
02 Jul 2023Reviewer(s) Assigned
13 Jul 2023Editorial Decision: Revise Major
31 Aug 20232nd Revision Received
04 Sep 2023Submission Checks Completed
04 Sep 2023Assigned to Editor
04 Sep 2023Review(s) Completed, Editorial Evaluation Pending
05 Sep 2023Editorial Decision: Accept
Dec 2023Published in Immunity, Inflammation and Disease volume 11 issue 12. https://doi.org/10.1002/iid3.1019